Expression of B cell markers on SR-4987 cells derived from murine bone marrow stroma

Pessina, A.; Neri, M.G.; Mineo, E.; Piccirillo, M.; Gribaldo, L.; Brambilla, P.; Zaleskis, G.; Ujházy, P.

Experimental Hematology 25(6): 536-541

1997


ISSN/ISBN: 0301-472X
PMID: 9197333
Document Number: 483383
The murine cell line SR-4987 was originated in our laboratory from adherent cells of a long term bone marrow culture. SR-4987 cells do not express p21-ras and c-fms products on membrane whereas secrete M-CSF, evidence a fibroblast-like morphology and are vimentine positive. This line shows a very poor "in vitro" agar clonogenicity which is not modulated by the addition of different cytokines and growth factors (M-CSF, GM-CSF, G-CSF, IL-3, IL-7, alpha-TNF, PDGF, and EGF). On the contrary, a dramatic increase in clonogenicity is observed in the presence of bFGF. The RT-PCR investigation evidences the mRNA encoding for bFGF, IL-7, GM-CSF, and SCF (c-kit ligand). The analysis of CD antigen expression on SR- 4987 cell membrane indicates a phenotype (CD5+,CD44+, 45R(B220)+, sIg+, 5'-nucleotidase+) that is consistent with a B cell feature. Our observations suggest that exogenous bFGF might represent an appropriate stimulus for inducing the SR-4987 cells proliferation also in the absence of cell-substrate anchorage. Further, they indicate that SR-4987 cells could represent a particular differentiation stage in which characters of "stromal cell" and "B cell" are coexpressed in agreement with the hypothesis of a common stromal-hematopoietic differentiation.

Document emailed within 1 workday
Secure & encrypted payments